The Types segment categorizes detection technologies into four core families, each with distinct methodological sub‑categories that shape adoption curves. Culture‑based methods remain the benchmark for quantifying viable organisms; sub‑types include selective agar plating, most‑probable‑number (MPN) assays, and enrichment‑broth protocols, collectively accounting for roughly 25 % of market revenue due to their regulatory acceptance despite longer turnaround times. Molecular techniques comprise polymerase‑chain‑reaction (PCR), quantitative PCR (qPCR), and next‑generation sequencing (NGS) platforms; their rapidity and sensitivity drive a 35 % share, especially in high‑throughput laboratories seeking strain‑level resolution. Immunological assays such as enzyme‑linked immunosorbent assay (ELISA), lateral‑flow immunochromatography, and chemiluminescent immunoassays provide a 20 % contribution, favored for on‑site screening where equipment footprints must remain minimal. Biosensor and rapid‑test kits integrate electrochemical, optical, or nanomaterial‑based transducers with proprietary reagents, capturing the remaining 20 % of spend as end‑users prioritize point‑of‑need diagnostics. This market taxonomy clarifies how each type’s performance attributes, cost structure, and regulatory status influence its proportional weight within the overall Seafood Microbiological Detection market.